HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 357 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $464,000 | +45.0% | 10,546 | +31.6% | 0.21% | +14.6% |
| Q1 2022 | $320,000 | -21.0% | 8,016 | -20.3% | 0.18% | -9.8% |
| Q4 2021 | $405,000 | +1.0% | 10,061 | +2.0% | 0.20% | -23.5% |
| Q3 2021 | $401,000 | +40.2% | 9,865 | -9.2% | 0.27% | +27.0% |
| Q3 2020 | $286,000 | +136.4% | 10,867 | +39.0% | 0.21% | +441.0% |
| Q3 2019 | $121,000 | -30.1% | 7,818 | -22.5% | 0.04% | -39.1% |
| Q2 2019 | $173,000 | – | 10,084 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |